发明名称 Mucosomal allergen-specific immunotherapy with initial dosing after start of pollen season
摘要 The present invention relates to mucosal allergen-specific immunotherapy with a seasonal allergen, wherein the therapy is initiated after start of the pollen season of the seasonal allergen. Preferably, the seasonal allergen is provided in solid dosage form and is administered daily. Furthermore, advantageously, the same dose may be used throughout the treatment period since up-dosing is not required.
申请公布号 US9248097(B2) 申请公布日期 2016.02.02
申请号 US200912988513 申请日期 2009.04.08
申请人 ALK-ABELLO A/S 发明人 Wustenberg Eike Gunther;Puchert Eckhard-Carl Albrecht
分类号 A61K38/00;A61K39/00;A61K39/35;A61K39/36;A61K39/38;A61K9/00 主分类号 A61K38/00
代理机构 Birch, Stewart, Kolasch & Birch, LLP 代理人 Birch, Stewart, Kolasch & Birch, LLP
主权项 1. A method for allergen specific immunotherapy for treating allergy to a seasonal allergen in an allergic patient, comprising sublingual administration of a solid dosage form of an allergen extract comprising said seasonal allergen, wherein said administration is in a mono-dose dosage regimen, and initial administration is performed within the allergen season of the seasonal allergen.
地址 Horsholm DK